 Intercept Pharmaceuticals Inc NASDAQ: ICPT has agreed to sell certain foreign subsidiaries and rights regarding its international operations, including a license to commercialize Ocaliva obeticholic acid outside of the U.S., to Advanz Pharma. Intercept will receive 405. 